𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Microglia in human immunodeficiency virus-associated neurodegeneration

✍ Scribed by Gwenn A. Garden


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
904 KB
Volume
40
Category
Article
ISSN
0894-1491

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Infection with the human immunodeficiency virus (HIV) is associated with a syndrome of cognitive and motor abnormalities that may develop in the absence of opportunistic infections. Neurons are not productively infected by HIV. Thus, one hypothesis to explain the pathophysiology of HIV‐associated dementia (HAD) suggests that signals released from other infected cell types in the CNS secondarily lead to neuronal injury. Microglia are the predominant resident CNS cell type productively infected by HIV‐1. Neurologic dysfunction in HAD appears to be a consequence of microglial infection and activation. Several neurotoxic immunomodulatory factors are released from infected and activated microglia, leading to altered neuronal function, synaptic and dendritic degeneration, and eventual neuronal apoptosis. This review summarizes findings from clinical/pathological studies, animal models, and in vitro models of HAD. Most of these studies support the hypothesis that altered microglial physiology is the nidus for a cascade of events leading to neuronal dysfunction and death. Several molecular mediators of neuronal injury in HAD that emanate from microglia have been identified, and strategies for altering the impact of these neurotoxins are discussed. GLIA 40:240–251, 2002. Β© 2002 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Lung cancer in association with human im
✍ Armando E. Fraire; Robert J. Awe πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 469 KB πŸ‘ 2 views

The association of lung cancer and infection by the human immunodeficiency virus (HIV) is uncommon. This report and critical review of the medical literature defines a clinical profile of 22 patients affected with this uncommon association. This clinical profile includes young age (median, 38 years)